Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis

Expert Review of Neurotherapeutics

Volumn 12, Issue 9, 2012, Pages 1079-1088

  Motl, Robert W ^a   Sandroff, Brian M ^a   Sosnoff, Jacob J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

accelerometers; ambulation; motion sensors; multiple sclerosis; walking

Indexed keywords

ACCELEROMETER; ACCELEROMETRY; GAIT; HUMAN; MEDICAL DEVICE; MEDICAL RESEARCH; MOBILIZATION; MONITORING; MULTIPLE SCLEROSIS; PATHOLOGY; PHYSICIAN; REVIEW; VALIDITY;

ACCELEROMETRY; EVIDENCE-BASED MEDICINE; GAIT DISORDERS, NEUROLOGIC; GREEN CHEMISTRY TECHNOLOGY; HUMANS; MOBILITY LIMITATION; MONITORING, AMBULATORY; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; WALKING;

EID: 84867307400     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.12.74     Document Type: Review

References (69)

1. National Multiple Sclerosis Society. Multiple Sclerosis Information Sourcebook. Information Resource Center and Library of the National Multiple Sclerosis Society, NY, USA (2005).
2. Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat. Clin. Pract. Neurol. 2(4), 201-211 (2006).
3. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247-269 (2008).
4. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N. Engl. J. Med. 343(20), 1430-1438 (2000).
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 33(11), 1444-1452 (1983).
6. Goldman MD, Motl RW, Rudick RA. Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther. Adv. Neurol. Disord. 3(4), 229-239 (2010).
7. Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient 4(3), 189-201 (2011).
8. Van Asch P. Impact of mobility impairment in multiple sclerosis 2: patients' perspectives. Eur. Neurol. Rev. 6(2), 115-120 (2011).
9. Fisher JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Multiple Sclerosis Functional Composite (MSFC): Administration and Scoring Manual. National Multiple Sclerosis Society, NY, USA, 1-44 (2002).
10. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult. Scler. 14(3), 383-390 (2008).
11. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care. Med. 166(1), 111-117 (2002).
12. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu. Rev. Clin. Psychol. 4, 1-32 (2008).
13. Pearson OR, Busse ME, van Deursen RW, Wiles CM. Quantification of walking mobility in neurological disorders. QJM 97(8), 463-475 (2004).
14. Cadavid D, Tang Y, O'Neill G. [Responsiveness of the Expanded Disability Status Scale (EDSS) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis]. Rev. Neurol. 51(6), 321-329 (2010).
15. Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, Polman CH. One year changes in disability in multiple sclerosis: neurological examination compared with patient self-report. J. Neurol. Neurosurg. Psychiatr. 74(4), 439-442 (2003).
16. Lublin FD. Clinical features and diagnosis of multiple sclerosis. Neurol. Clin. 23(1), 1-15, v (2005).
17. Givon U, Zeilig G, Achiron A. Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system. Gait Posture 29(1), 138-142 (2009).
18. Sosnoff JJ, Weikert M, Dlugonski D, Smith DC, Motl RW. Quantifying gait impairment in multiple sclerosis using GAITRite technology. Gait Posture 34(1), 145-147 (2011).
19. Martin CL, Phillips BA, Kilpatrick TJ et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult. Scler. 12(5), 620-628 (2006).
20. Sosnoff JJ, Sandroff BM, Motl RW. Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability. Gait Posture 36(1), 154-156 (2012).
21. Saunders JB, Inman VT, Eberhart HD. The major determinants in normal and pathological gait. J. Bone Joint Surg. Am. 35-A(3), 543-558 (1953).
22. Servais SB, Webster JG, Montoye HJ. Estimating human energy expenditure using an accelerometer device. J. Clin. Eng. 9(2), 159-170 (1984).
23. Montoye HJ, Kemper HCG, Sarris WHM, Washburn RA. Measuring Physical Activity and Energy Expenditure. Human Kinetics, Champaign, IL, USA (1996).
24. Gibbs-Smith C. The Inventions of Leonardo da Vinci. Phaidon Press Ltd, London, UK, 31-43 (1978).
25. Paletta LA, Worth FL. World Almanac of Presidential Facts. Pharos Books, Indiana University, NY, USA (1993).
26. Amar J. The Human Motor. George Routledge & Sons, Ltd., London, UK (1920).
27. Verschuur R, Kemper HCG. Adjustment of pedometers to make them more valid in assessing running. Int. J. Sports. Med. 1, 95-97 (1980).
28. Elsworth C, Dawes H, Winward C et al. Pedometer step counts in individuals with neurological conditions. Clin. Rehabil. 23(2), 171-175 (2009).
29. Le Masurier GC, Tudor-Locke C. Comparison of pedometer and accelerometer accuracy under controlled conditions. Med. Sci. Sports Exerc. 35(5), 867-871 (2003).
30. Motl RW, McAuley E, Snook EM, Scott JA. Accuracy of two electronic pedometers for measuring steps taken under controlled conditions among ambulatory individuals with multiple sclerosis. Mult. Scler. 11(3), 343-345 (2005).
31. Meijer GA, Westerterp KR, Verhoeven FM, Koper HB, ten Hoor F. Methods to assess physical activity with special reference to motion sensors and accelerometers. IEEE Trans. Biomed. Eng. 38(3), 221-229 (1991).
32. Motl RW, Snook EM, Agiovlasitis S. Does an accelerometer accurately measure steps taken under controlled conditions in adults with mild multiple sclerosis? Disabil. Health J. 4(1), 52-57 (2011).
33. Ng AV, Kent-Braun JA. Quantitation of lower physical activity in persons with multiple sclerosis. Med. Sci. Sports Exerc. 29(4), 517-523 (1997).
34. Motl RW. Physical activity and its measurement and determinants in multiple sclerosis. Minerva Med. 99(2), 157-165 (2008).
35. Hale LA, Pal J, Becker I. Measuring free-living physical activity in adults with and without neurologic dysfunction with a triaxial accelerometer. Arch. Phys. Med. Rehabil. 89(9), 1765-1771 (2008).
36. Klassen L, Schachter C, Scudds R. An exploratory study of two measures of free-living physical activity for people with multiple sclerosis. Clin. Rehabil. 22(3), 260-271 (2008).
37. Snook EM, Motl RW, Gliottoni RC. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis. Clin. Rehabil. 23(3), 248-258 (2009).
38. Weikert M, Motl RW, Suh Y, McAuley E, Wynn D. Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility? J. Neurol. Sci. 290(1-2), 6-11 (2010).
39. Weikert M, Suh Y, Lane A et al. Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis. Med. Eng. Phys. 34(5), 590-597 (2012).
40. Sosnoff JJ, Goldman MD, Motl RW. Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data. Mult. Scler. 16(7), 868-877 (2010).
41. Weikert M, Dlugonski D, Balantrapu S, Motl RW. Most common types of physical activity self-selected by people with multiple sclerosis. Int. J. MS Care 13, 16-20 (2011).
42. Rietberg MB, van Wegen EE, Uitdehaag BM, de Vet HC, Kwakkel G. How reproducible is home-based 24-hour ambulatory monitoring of motor activity in patients with multiple sclerosis? Arch. Phys. Med. Rehabil. 91(10), 1537-1541 (2010).
43. Sosnoff JJ, Socie MJ, Boes MK, Sandroff BM, Suh Y, Motl RW. Ambulatory mobility monitoring in people with multiple sclerosis. J. Rehabil. Res. Dev. (2012) (In Press).
44. Motl RW, Sosnoff JJ, Dlugonski D, Suh Y, Goldman M. Does a waist-worn accelerometer capture intra-and interperson variation in walking behavior among persons with multiple sclerosis? Med. Eng. Phys. 32(10), 1224-1228 (2010).
45. Motl RW, Snook EM, Agiovlasitis S, Suh Y. Calibration of accelerometer output for ambulatory adults with multiple sclerosis. Arch. Phys. Med. Rehabil. 90(10), 1778-1784 (2009).
46. Sandroff BM, Motl RW, Suh Y. Accelerometer output and its association with energy expenditure in persons with multiple sclerosis. J. Rehabil. Res. Dev. 49(3), 467-476 (2012).
47. Motl RW, Weikert M, Suh Y et al. Accuracy of the ActiBelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis. Gait Posture 35(2), 192-196 (2012).
48. Kayes NM, Schluter PJ, McPherson KM, Leete M, Mawston G, Taylor D. Exploring actical accelerometers as an objective measure of physical activity in people with multiple sclerosis. Arch. Phys. Med. Rehabil. 90(4), 594-601 (2009).
49. Motl RW, Dlugonski D, Suh Y, Weikert M, Fernhall B, Goldman M. Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis. Arch. Phys. Med. Rehabil. 91(12), 1942-1947 (2010).
50. Motl RW, McAuley E. Association between change in physical activity and short-term disability progression in multiple sclerosis. J. Rehabil. Med. 43(4), 305-310 (2011).
51. Motl RW, McAuley E. Pathways between physical activity and quality of life in adults with multiple sclerosis. Health Psychol. 28(6), 682-689 (2009).
52. Vercoulen JH, Bazelmans E, Swanink CM et al. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J. Psychiatr. Res. 31(6), 661-673 (1997).
53. Busse ME, Pearson OR, Van Deursen R, Wiles CM. Quantified measurement of activity provides insight into motor function and recovery in neurological disease. J. Neurol. Neurosurg. Psychiatr. 75(6), 884-888 (2004).
54. Cavanaugh JT, Gappmaier VO, Dibble LE, Gappmaier E. Ambulatory activity in individuals with multiple sclerosis. J. Neurol. Phys. Ther. 35(1), 26-33 (2011).
55. Gijbels D, Alders G, Van Hoof E et al. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult. Scler. 16(5), 618-626 (2010).
56. Schmidt AL, Pennypacker ML, Thrush AH, Leiper CI, Craik RL. Validity of the StepWatch Step Activity Monitor: preliminary findings for use in persons with Parkinson disease and multiple sclerosis. J. Geriatr. Phys. Ther. 34(1), 41-45 (2011).
57. Motl RW, Zhu W, Park Y, McAuley E, Scott JA, Snook EM. Reliability of scores from physical activity monitors in adults with multiple sclerosis. Adapt. Phys. Activ. Q. 24(3), 245-253 (2007).
58. Motl RW, McAuley E, Dlugonski D. Reactivity in baseline accelerometer data from a physical activity behavioral intervention. Health Psychol. 31(2), 172-175 (2012).
59. Harris TJ, Owen CG, Victor CR, Adams R, Ekelund U, Cook DG. A comparison of questionnaire, accelerometer, and pedometer: measures in older people. Med. Sci. Sports Exerc. 41(7), 1392-1402 (2009).
60. Mâsse LC, Fuemmeler BF, Anderson CB et al. Accelerometer data reduction: a comparison of four reduction algorithms on select outcome variables. Med. Sci. Sports Exerc. 37(Suppl. 11), S544-S554 (2005).
61. Motl RW, Sandroff BM. Objective monitoring of physical activity behavior in multiple sclerosis. Phys. Ther. Rev. 15(3), 204-211 (2010).
62. Paul DR, Kramer M, Moshfegh AJ, Baer DJ, Rumpler WV. Comparison of two different physical activity monitors. BMC Med. Res. Methodol. 7, 26 (2007).
63. Gosney JL, Scott JA, Snook EM, Motl RW. Physical activity and multiple sclerosis: validity of self-report and objective measures. Fam. Comm. Health 30(2), 144-150 (2007).
64. Schimpl M, Moore C, Lederer C et al. Association between walking speed and age in healthy, free-living individuals using mobile accelerometry-a cross-sectional study. PLoS ONE 6(8), e23299 (2011).
65. Costelloe L, O'Rourke K, Kearney H et al. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J. Neurol. Neurosurg. Psychiatr. 78(8), 841-844 (2007).
66. Hobart J. Prolonged-release fampridine for multiple sclerosis: was the effect on walking ability clinically significant. Mult. Scler. 16 S172 (2010).
67. Lockhart TE, Barth AT, Zhang X, Songra R, Abdel-Rahman E, Lach J. Portable, noninvasive fall risk assessment in end stage renal disease patients on hemodialysis. ACM Trans. Comput. Hum. Interact., 84-93 (2010).
68. Sosnoff JJ, Socie MJ, Boes MK et al. Mobility, balance and falls in persons with multiple sclerosis. PLoS ONE 6(11), e28021 (2011).
69. Peterson EW, Cho CC, Finlayson ML. Fear of falling and associated activity curtailment among middle aged and older adults with multiple sclerosis. Mult. Scler. 13(9), 1168-1175 (2007).